Inspira Technologies OXY B.H.N. Ltd. announced the appointment of Dr. Dan Gorfil to its medical advisory board. Dr. Gorfil is a distinguished specialist in cardiac surgery and intensive care medicine. Dr. Gorfil is both the head of the Cardiothoracic Surgery Intensive Care Unit and the Extracorporeal Membrane Oxygenation program at the Department of Cardiothoracic Surgery at Rabin Medical Center, Israel.

Dr. Gorfil?s expertise is expected to significantly contribute to the deployment of the INSPIRA? ART100. U.S. Food and Drug Administration (FDA) approval is expected in the first half of 2024.